Highlights
AMEX: INO       Inovio Pharma
Last Price Today's Change   Day's Range   Trading Volume
25.62   +2.24 (9.58%)  22.65 - 28.541  57,149,300

Overview

 
Avg Volume (4 weeks):60,938,995
4 Weeks Range:12.55 - 33.79
4 Weeks Price Volatility (%):
61.53%
52 Weeks Range:1.915 - 33.79
52 Weeks Price Volatility (%):
74.37%
Average Price Target: 0.70
Price Target Upside/Downside: -24.92

Headlines



No recent Headlines for this stock.


Business Background

Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

  Be the first to like this.
 
selamba so good counter
05/08/2013 8:11 PM


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1593  6746  454  130 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 13.84-1.14 
 SQQQ 6.56+0.38 
 LK 1.38+1.38 
 ECOR 1.78+0.93 
 VXRT 12.12+4.14 
 SPY 314.84-2.75 
 XLF 23.56+0.10 
 HTBX 1.28+0.27 
 EQ 26.50+23.31 
 TOPS 0.105-0.006 
Partners & Brokers